Angela Woodiwiss to Adrenergic beta-Agonists
This is a "connection" page, showing publications Angela Woodiwiss has written about Adrenergic beta-Agonists.
Connection Strength
2,881
-
Limited Impact of ß-Adrenergic Receptor Activation on Left Ventricular Diastolic Function in Rat Models of Hypertensive Heart Disease. J Cardiovasc Pharmacol. 2018 11; 72(5):242-251.
Score: 0,623
-
Prevention of ßeta-adrenergic-induced Adverse Cardiac Remodeling by Gonadectomy in Male but Not Female Spontaneously Hypertensive Rats. J Cardiovasc Pharmacol. 2017 Sep; 70(3):202-209.
Score: 0,575
-
Reverse chamber remodelling following adrenergic-induced advanced cardiac dilatation and pump dysfunction. Basic Res Cardiol. 2012 Jan; 107(1):238.
Score: 0,387
-
Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats. J Cardiovasc Pharmacol. 2010 Aug; 56(2):203-11.
Score: 0,352
-
Impact of chronic beta-adrenoceptor activation on neurotensin-induced myocardial effects in rats. Eur J Pharmacol. 2006 Dec 28; 553(1-3):246-53.
Score: 0,269
-
Impact of castration on changes in left ventricular diastolic pressure-volume relations induced by chronic adrenergic stimulation in rats. J Cardiovasc Pharmacol. 2014 Jun; 63(6):562-6.
Score: 0,115
-
Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats. Eur J Appl Physiol. 2013 Nov; 113(11):2803-11.
Score: 0,109
-
Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats. Pflugers Arch. 2007 Nov; 455(2):251-60.
Score: 0,071
-
Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation. Am J Physiol Heart Circ Physiol. 2007 Apr; 292(4):H1898-905.
Score: 0,068
-
Mechanisms of preserved baseline cardiac systolic function in rats with adrenergic inotropic downregulation. Life Sci. 2005 Dec 12; 78(4):366-75.
Score: 0,062
-
Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation. Hypertension. 2005 May; 45(5):914-20.
Score: 0,061
-
A phosphodiesterase inhibitor promotes the premature development of adverse cardiac remodelling mediated by beta-adrenergic activation in hypertension. S Afr Med J. 2004 Oct; 94(10):833-4.
Score: 0,059
-
Beta-adrenergic activation initiates chamber dilatation in concentric hypertrophy. Hypertension. 2003 Mar; 41(3):499-504.
Score: 0,052
-
Adenosine A2a-receptor activation enhances cardiomyocyte shortening via Ca2+-independent and -dependent mechanisms. Am J Physiol. 1999 05; 276(5):H1434-41.
Score: 0,040
-
Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation. Pflugers Arch. 2006 May; 452(2):155-63.
Score: 0,016
-
Antiadrenergic effects of adenosine in pressure overload hypertrophy. Hypertension. 2001 Mar; 37(3):862-8.
Score: 0,011
-
Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens. 2000 Feb; 18(2):167-72.
Score: 0,011